Registration for a live webinar on 'The role of T cells in COVID from asymptomatic to severe outcomes' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disclosures
- Overview
- Phosphate is vital for several key biological processes
- Phosphate homeostasis regulation
- Key players in phosphate homeostasis
- Pathophysiology of acute hypophosphataemia
- Pathophysiology of chronic hypophosphataemia
- Symptoms of low phosphate
- Biochemical investigations
- Disorders of hypophosphataemia
- Case study 1
- Case study 1: 3.5-year-old boy
- Case study 1: clinical presentation
- Case study 1: biochemical picture
- Approach to hypophosphataemia
- Case study 1: management
- Preventing nutritional rickets
- Case study 2
- Case study 2: 3.5-year-old boy
- Case study 2: progress
- Case study 2: biochemical picture
- Approach to hypophosphataemia
- Differentials of FGF23-mediated hypophosphataemia
- X-linked hypophosphataemia
- Autosomal dominant hypophosphataemic rickets
- ARHR type 1
- ARHR type 2 (ARHR2)
- ARHR2
- ARHR type 3 (ARHR 3)
- Fibrous Dysplasia (FD)
- Fibrous dysplasia
- Tumour-Induced Osteomalacia (TIO)
- TIO: clinical features
- TIO & imaging
- Approach to hypophosphataemia
- Hypophosphataemic rickets with hypercalciuria
- Fanconi syndrome
- Summary
Topics Covered
- The spectrum of hypophosphataemia in children
- Phosphate homeostasis
- Pathophysiology of hypophosphataemia
- Acute and chronic hypophosphataemia
- Management of hypophosphataemia
- Rickets
- Hereditary Hypophosphataemic Rickets with Hypercalciuria (HHRH)
- Tumour Induced Osteomalacia (TIO)
- X linked hypophosphataemia (XLH)
- FGF23-mediated hypophosphataemia
- Autosomal Dominant Hypophosphataemic Rickets (ADHR)
- Autosomal Recessive Hypophosphataemic Rickets (ARHR)
- Fibrous Dysplasia (FD)
- Fanconi syndrome
Links
Categories:
Therapeutic Areas:
External Links
Talk Citation
Uday, S. (2024, March 31). Spectrum of hypophosphatemia in children [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved May 3, 2024, from https://hstalks.com/bs/5589/.Export Citation (RIS)
Publication History
Financial Disclosures
- Honorarium, travel grants and research grants from Alexion, Kyowa Kirin, Novo Nordisk, Sanofi, Internis. Expert panel member on the International Hypophosphataemia Network, a Kyowa Kirin information hub for healthcare professionals